Wednesday, April 15, 2026

Pharmalittle: FDA Advocates for Trial Transparency and Novo’s Partnership with OpenAI

Today on the Pharmalot campus, we’re excited to start our day with elderberry-infused green tea, a blend enhanced by honey. We invite you to join us in this delightful moment! In healthcare news, the FDA has sent reminder letters to over 2,200 companies regarding mandatory clinical trial reporting to a federal database. Nearly 30% of studies likely needing reporting have not submitted results, stifling duplication and understanding of medical data. Additionally, Novo Nordisk is partnering with OpenAI to utilize artificial intelligence for drug discovery. This collaboration aims to streamline operations and reduce the time required for bringing new treatments from research to patients. Initial pilot programs will focus on research, development, and manufacturing efficiencies before full AI integration later this year. Stay updated for more insights on these developments!

Source link

Share

Read more

Local News